ERT Launches New Online Gateway to Improve Cardiac Safety in Clinical Trials
July 07 2009 - 10:00AM
PR Newswire (US)
PHILADELPHIA, July 7 /PRNewswire-FirstCall/ -- ERT (NASDAQ:ERES), a
leading provider of centralized ECG, ePRO, eClinical technology and
other services to the biopharmaceutical, medical device and related
industries, announced today the launch of a unique online web
interface - My Study Portal(TM). Following the successful launch of
ERT's new website (http://www.ert.com/), My Study Portal is aimed
at enhancing the accuracy and efficiency of cardiac safety data
management in clinical trials. My Study Portal, which replaces the
previous Digital ECG Community, is an easy to use web-based portal
which provides users with secure 24/7 access to a centralized
environment to view and manage vital data, from anywhere in the
world -- on demand, in real time. ERT's My Study Portal is the
industry's only dedicated, 21 CFR Part 11-compliant, clinical trial
portal. Julie Nelson, ERT's Director of Online Reporting Services,
states, "We are very excited with the launch of our new My Study
Portal product, built upon our proven web-based software solutions.
This system provides a comprehensive toolset for monitoring cardiac
safety and delivers significant enhancements to our clinical teams.
With the advent of site-specific tools to view and respond to
queries, order ECG-related supplies and create reports with
up-to-the-minute information, this product will drive cost-savings
across the entire cardiac safety management process." This new
portal has been designed for use by both sponsor personnel and
investigator sites. Sites can self-qualify and access information
on-line in real time including annotated ECG waveforms, resolve
queries, order supplies and access key study information. Study
personnel with differing responsibilities, such as clinical trial
managers, CRAs, principal investigators and medical monitors, can
use the portal to track the progress of their clinical trials. Key
information is continuously updated including - ECG findings and
interpretations, ECG quality, abnormalities, query resolution and
other key study metrics. My Study Portal is powered by ERT's
proprietary EXPERT(TM) Technology Platform - a robust, secure and
validated clinical-research workflow-processing technology that
powers centralized electronic data collection, data management and
information exchange. The EXPERT platform is tailored for the
unique requirements of ERT's Cardiac Safety and ePRO Solutions.
Study data reports can be easily generated against live data from
the EXPERT data management system - other than the full custom data
set several types of standard reports are available including study
and visit tracking, missing visits, unresolved queries,
comprehensive ECG analysis, abnormal ECGs and trial summary. Unlike
traditional static reporting portals, this new interactive portal
facilitates a wide variety of customer support initiatives from
supply ordering to retrieving real time key ECG information that
can be reviewed and analyzed by cardiologists immediately. The
Electronic Query Resolution feature allows sponsors and sites to
review unresolved queries and respond within seconds. ECG results,
findings and alerts can be reviewed in pre-filtered listings and
configurable reports using the Live ECG Gateway. Site Qualification
forms can also be submitted digitally to ERT for immediate
approval. The ERT customer care and technical support team is on
hand 24/7 and resource materials, such as equipment manuals and
quick reference guides, can be posted on-line for access anytime
during the study process. This comprehensive set of on-line tools
provides functionality to improve the setup, planning and closeout
processes of all clinical trials. The content and reporting tools
are organized into separate modules that are continuously updated
as ECGs are processed to provide up-to-the-minute cardiac data in a
clear and concise format. For further information on ERT and its
technology and services please email , call +1 215 972 0420 or
visit http://www.ert.com/. About ERT Based in Philadelphia, Pa, ERT
(eResearchTechnology, Inc.) (http://www.ert.com/) is a provider of
technology and services to the biopharmaceutical and medical device
industries on a global basis. The company is a market leader in
providing centralized core-diagnostic electrocardiographic (ECG)
technology and services to evaluate cardiac safety in clinical
development. The company is also a leader in providing technology
and services to streamline the clinical trials process by enabling
its customers to automate the collection, analysis and distribution
of clinical data in all phases of clinical development. Statements
included in this release may constitute forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. Such statements, including, but not limited to, 2009
financial guidance, involve a number of risks and uncertainties
such as the Company's ability to obtain new contracts and
accurately estimate net revenues due to uncertain regulatory
guidance, variability in size, scope and duration of projects, and
internal issues at the sponsoring client, integration of
acquisitions, competitive factors, technological development, and
market demand. As a result, actual results may differ materially
from any financial outlooks stated herein. Further information on
potential factors that could affect the Company's financial results
can be found in the Company's Reports on Form 10-K and 10-Q filed
with the Securities and Exchange Commission. The Company undertakes
no obligation to publicly update any forward-looking statement,
whether as a result of new information, future events, or
otherwise. DATASOURCE: ERT CONTACT: Fiona Robinson of The Scott
Partnership, +44 1477 539539, , or John Blakeley of ERT,
+1-215-972-0420, Web Site: http://www.ert.com/
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024